Matthew Watson[email protected]Market AnalysisThe rocky road to implementing CT lung cancer screeningWhat are the major hurdles facing the organizers of large-scale CT lung cancer screening programs? And what are the future market trends in this area? Analyst Matthew Watson provides some answers in a new column.May 17, 2023Page 1 of 1Top StoriesMolecular ImagingDublin team evaluates radiation dose in PSMA PET/CTReducing average injected dose and uptake time in prostate-specific membrane antigen (PSMA) PET/CT can lead to improved patient throughput, according to Irish researchers.CTBelgium moves ahead with novel radiology referral schemeCTAssessing CT image quality: Which method is best?CTCT pearls from Ireland’s top orthopedic hospitalMolecular ImagingSPECT/CT identifies prostate cancer patients with poor outcomes